Third Arc Bio

Boston, United States

Third Arc Bio is a biotech company developing multifunctional antibodies for inflammatory and immunology diseases.

$52.0M raised

Feb 2026

Series A

Biotechnology Health Care Life Science Medical Oncology

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Third Arc Bio

How much funding has Third Arc Bio raised?

Third Arc Bio has raised $52.0M in total funding. The most recent round was Series A. The last funding was announced in February 2026.

Where is Third Arc Bio headquartered?

Third Arc Bio is headquartered in Boston, United States.

What does Third Arc Bio do?

Third Arc Bio is a biotech company developing multifunctional antibodies for inflammatory and immunology diseases.

What stage is Third Arc Bio at?

Third Arc Bio is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated February 4, 2026.

MLA

"Third Arc Bio — Funding & Investors." VCBacked, February 4, 2026, https://www.vcbacked.co/company/third-arc-bio. Accessed July 4, 2026.

APA

VCBacked. (2026). Third Arc Bio — Funding & Investors. Retrieved July 4, 2026, from https://www.vcbacked.co/company/third-arc-bio

Wikipedia (cite web)

{{cite web |title=Third Arc Bio — Funding & Investors |url=https://www.vcbacked.co/company/third-arc-bio |website=VCBacked |access-date=July 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated February 4, 2026.

Similar Companies in Biotechnology

View all

Rapport Therapeutics

Boston$250.0M

Allterum Therapeutics

Houston$1.0M

AlpalifeBio

Woburn$9.8M

Renaissance BioScience

Vancouver$599K

Epsilogen

London$16.3M

Advanced Microbiome Interventions

Amsterdam$300K